Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fusion protein or fusion polypeptide
Patent
1993-04-26
1994-09-27
Kim, Kay K.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fusion protein or fusion polypeptide
4242041, 435 693, 435 697, 4352402, 4352523, 4353201, 536 234, 536 2372, 530350, 530403, A61K 3912, C12N 1509, C12N 121, C07K 1512
Patent
active
053505751
ABSTRACT:
A recombinant DNA molecule comprising a nucleotide sequence coding for a conformational epitope of the VP2 polypeptide of IBDV. In particular, a DNA molecule comprising a sequence which substantially corresponds to the AccI-SpeI fragment, and optionally the ScaI-XhoI fragment, of the IBDV genome segment coding for the VP2 polypeptide. Synthetic peptides or polypeptides, including fused polypeptides, prepared by expression of host cells containing these DNA molecules are also disclosed, as well as compositions for stimulating an immune response against IBDV comprising at least one such synthetic peptide or polypeptides.
REFERENCES:
Azad et al., (1985), Virology, 143:35-44.
Fahey et al., (1985), J. Gen. Virol., 66:2693-2702.
Fahey et al., (1985b), J. Gen. Virol., 66:1479-1488.
Hudson et al., (1986), Nucl. Acids. Res., 14(12):5001-12.
Azad Ahmed A.
Fahey Kevin J.
Jagadish Mittur N.
Commonwealth Scientific and Industrial Research Organization
Kim Kay K.
LandOfFree
IBDV VP2 epitope recognized by virus neutralizing and protective does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IBDV VP2 epitope recognized by virus neutralizing and protective, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IBDV VP2 epitope recognized by virus neutralizing and protective will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1264289